Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology) - Image 1

£166.54

Springer Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology)

Name: Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology)
Brand: Springer
Price: 166.54 GBP
Availability: InStock

Pharmacy - Dispensing

This is the usual price. Wait for it to drop, or tell us your number.

£167 today · usual range £146–£169 · best ever £146

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 48 days · 48 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 48 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £168 (42 days, 87.5%)

Price range: £146 - £168

Price levels: 3 different prices over 48 days

Description

The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1475792115
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Publication Date: 25 April 2013
Listed Since: 20 September 2013

Barcode

No barcode data available

Springer Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Antiviral Drugs and Interferon: The Molecular Basis of Their Activity: The Molecular Basis of Their Activity: 4 (Developments in Molecular Virology, 4)

Antiviral Chemotherapy 5: New Directions for Clinical Application and Research: 458 (Advances in Experimental Medicine and Biology, 458)

Biopharmaceutics and Drug Hypersensitivity (Pharmacology - Research, Safety Testing and Regulation)

Chemotherapy of Viral Infections: 61 (Handbook of Experimental Pharmacology)

The 2025-2030 World Outlook for Genital Herpes Treatments

Antiviral Methods and Protocols: 24 (Methods in Molecular Medicine, 24)

Immunobiology and Prophylaxis of Human Herpesvirus Infections: 278 (Advances in Experimental Medicine and Biology, 278)

Human Herpesviruses HHV-6A, HHV-6B & HHV-7: Diagnosis and Clinical Management: Volume 12 (Perspectives in Medical Virology, Volume 12)

Current Topics in Microbiology and Immunology: 97

Gene Therapy for HIV and Chronic Infections: 848 (Advances in Experimental Medicine and Biology, 848)

Herpesviruses, the Immune System, and AIDS: 6 (Developments in Medical Virology, 6)

The Herpesviruses (The Viruses)

Medical Virology 8

Advances in Antiviral Drug Design (Volume 3)

Viral Infections and Antiviral Therapies

Human Herpesvirus-6: General Virology, Epidemiology, and Clinical Pathology (Volume 12) (Perspectives in Medical Virology, Volume 12)

Herpes Simplex Virus: Methods and Protocols: 1144 (Methods in Molecular Biology, 1144)

Alphaherpesviruses: Molecular Biology, Host Interactions and Control

The CAPRISA Clinical Trials: HIV Treatment and Prevention

Antiviral Discovery for Highly Pathogenic Emerging Viruses: Volume 80 (Drug Discovery Series)

Herpesviridae: Viral Structure, Life Cycle and Infections: Viral Structure, Life Cycle & Infections

Vaccinia Virus: Methods and Protocols: 2023 (Methods in Molecular Biology, 2023)

Antiviral Methods and Protocols: 1030 (Methods in Molecular Biology, 1030)